4.8 Article

Sex differences in heart mitochondria regulate diastolic dysfunction

Related references

Note: Only part of the references are listed.
Review Cardiac & Cardiovascular Systems

Metabolic inflammation in heart failure with preserved ejection fraction

Gabriele G. Schiattarella et al.

Summary: HFpEF is a common chronic cardiovascular disease, where metabolic disturbance and inflammatory burden play important roles in its pathogenesis. The interplay between these two processes is complex, with metabolic inflammation having a central role in shaping the pathophysiology of HFpEF.

CARDIOVASCULAR RESEARCH (2021)

Article Biochemistry & Molecular Biology

Imeglimin prevents heart failure with preserved ejection fraction by recovering the impaired unfolded protein response in mice subjected to cardiometabolic stress

Hiroki Kitakata et al.

Summary: Imeglimin improves cardiac abnormalities in obese diabetic patients with HFpEF by suppressing iNOS upregulation, restoring Xbp1s expression, and regulating FoxO1 transcriptional activity, which reduces cardiac adipogenesis and HFpEF development.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Article Cardiac & Cardiovascular Systems

Early adaptive chromatin remodeling events precede pathologic phenotypes and are reinforced in the failing heart

Douglas J. Chapski et al.

Summary: The study revealed that chromatin remodeling during early compensation after pathologic stimuli persists into the later decompensatory phases of heart failure. The findings provide insights into how local chromatin features govern gene expression within the context of global genomic structure and highlight chromatin remodeling events that could be targeted for therapeutic interventions in disease.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

NAD+ Repletion Reverses Heart Failure With Preserved Ejection Fraction

Dan Tong et al.

Summary: The study demonstrated through a mouse model that HFpEF is associated with myocardial mitochondrial dysfunction, and NAD(+) supplementation is considered a promising therapeutic approach.

CIRCULATION RESEARCH (2021)

Article Multidisciplinary Sciences

Xbp1s-FoxO1 axis governs lipid accumulation and contractile performance in heart failure with preserved ejection fraction

Gabriele G. Schiattarella et al.

Summary: HFpEF, a major health issue globally, lacks effective therapies. The interaction between two transcription factors, Xbp1s and FoxO1, is crucial for metabolic adaptation and lipid handling in HFpEF-stressed cardiomyocytes.

NATURE COMMUNICATIONS (2021)

Review Cardiac & Cardiovascular Systems

Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models

Coenraad Withaar et al.

Summary: HFpEF is a multifactorial disease with no proven therapy to improve outcomes, leading to challenges in drug development. Recent clinical algorithms aimed to improve and standardize the diagnosis of HFpEF. However, most pre-clinical HFpEF models do not fully meet clinical criteria, highlighting the need for novel approaches in model development.

EUROPEAN HEART JOURNAL (2021)

Article Medicine, General & Internal

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

Stefan D. Anker et al.

Summary: Empagliflozin reduces the risk of cardiovascular death or hospitalization for heart failure in patients with heart failure and a preserved ejection fraction, regardless of the presence or absence of diabetes.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Endocrinology & Metabolism

Testosterone Supplementation in Patients With Chronic Heart Failure: A Meta-Analysis of Randomized Controlled Trials

Jianping Tao et al.

FRONTIERS IN ENDOCRINOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Mitochondrial Dysfunction in Heart Failure With Preserved Ejection Fraction

Anupam A. Kumar et al.

CIRCULATION (2019)

Review Endocrinology & Metabolism

Sex-specific influence on cardiac structural remodeling and therapy in cardiovascular disease

Elise L. Kessler et al.

BIOLOGY OF SEX DIFFERENCES (2019)

Article Cardiac & Cardiovascular Systems

Medical Therapy for Heart Failure Caused by Ischemic Heart Disease

Islam Y. Elgendy et al.

CIRCULATION RESEARCH (2019)

Article Multidisciplinary Sciences

Nitrosative stress drives heart failure with preserved ejection fraction

Gabriele G. Schiattarella et al.

NATURE (2019)

Article Multidisciplinary Sciences

Pathologic gene network rewiring implicates PPP1R3A as a central regulator in pressure overload heart failure

Pablo Cordero et al.

NATURE COMMUNICATIONS (2019)

Review Medicine, General & Internal

Sex and Heart Failure with Preserved Ejection Fraction: From Pathophysiology to Clinical Studies

Marijana Tadic et al.

JOURNAL OF CLINICAL MEDICINE (2019)

Article Cell Biology

Gene-by-Sex Interactions in Mitochondria! Functions and Cardio-Metabolic Traits

Frode Norheim et al.

CELL METABOLISM (2019)

Article Multidisciplinary Sciences

Gender-related differences in heart failure with preserved ejection fraction

Franz Duca et al.

SCIENTIFIC REPORTS (2018)

Article Endocrinology & Metabolism

Sex Differences in Cardiac Mitochondria in the New Zealand Obese Mouse

Cathleen John et al.

FRONTIERS IN ENDOCRINOLOGY (2018)

Article Cardiac & Cardiovascular Systems

Mitochondrial function as a therapeutic target in heart failure

David A. Brown et al.

NATURE REVIEWS CARDIOLOGY (2017)

Review Cardiac & Cardiovascular Systems

Epidemiology of heart failure with preserved ejection fraction

Shannon M. Dunlay et al.

NATURE REVIEWS CARDIOLOGY (2017)

Review Biochemistry & Molecular Biology

The Hybrid Mouse Diversity Panel: a resource for systems genetics analyses of metabolic and cardiovascular traits

Aldons J. Lusis et al.

JOURNAL OF LIPID RESEARCH (2016)

Article Genetics & Heredity

Integrative approaches for large-scale transcriptome-wide association studies

Alexander Gusev et al.

NATURE GENETICS (2016)

Article Cell Biology

Genetic Architecture of Insulin Resistance in the Mouse

Brian W. Parks et al.

CELL METABOLISM (2015)

Article Cardiac & Cardiovascular Systems

Sex Differences in the Prevalence of Diastolic Dysfunction in Cardiac Surgical Patients

Renata G. Ferreira et al.

JOURNAL OF CARDIAC SURGERY (2015)

Article Genetics & Heredity

High-Density Genotypes of Inbred Mouse Strains: Improved Power and Precision of Association Mapping

Christoph D. Rau et al.

G3-GENES GENOMES GENETICS (2015)

Article Cardiac & Cardiovascular Systems

Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population

Richard K. Cheng et al.

AMERICAN HEART JOURNAL (2014)

Article Cardiac & Cardiovascular Systems

Predictors of New-Onset Heart Failure Differences in Preserved Versus Reduced Ejection Fraction

Jennifer E. Ho et al.

CIRCULATION-HEART FAILURE (2013)

Review Cardiac & Cardiovascular Systems

Heart failure: What does ejection fraction have to do with it?

Hiroyuki Iwano et al.

JOURNAL OF CARDIOLOGY (2013)

Review Cardiac & Cardiovascular Systems

Epidemiology and clinical course of heart failure with preserved ejection fraction

Carolyn S. P. Lam et al.

EUROPEAN JOURNAL OF HEART FAILURE (2011)

Article Biochemistry & Molecular Biology

A high-resolution association mapping panel for the dissection of complex traits in mice

Brian J. Bennett et al.

GENOME RESEARCH (2010)

Article Medicine, General & Internal

Trends in prevalence and outcome of heart failure with preserved ejection fraction

Theophilus E. Owan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Cardiac & Cardiovascular Systems

Age- and gender-related ventricular-vascular stiffening - A community-based study

MM Redfield et al.

CIRCULATION (2005)

Article Cardiac & Cardiovascular Systems

Heart failure with preserved left ventricular Systolic function - Epidemiology clinical characteristics and prognosis

K Hogg et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)